Takeshi Isoyama

1.0k total citations
30 papers, 620 citations indexed

About

Takeshi Isoyama is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Takeshi Isoyama has authored 30 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Takeshi Isoyama's work include Lung Cancer Treatments and Mutations (5 papers), Acute Myeloid Leukemia Research (3 papers) and Cancer Mechanisms and Therapy (3 papers). Takeshi Isoyama is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Acute Myeloid Leukemia Research (3 papers) and Cancer Mechanisms and Therapy (3 papers). Takeshi Isoyama collaborates with scholars based in Japan, Germany and United States. Takeshi Isoyama's co-authors include Akio Nomoto, Shusuke Kuge, Hideaki Toyoshima, Asako Murayama, Kazuko Shiroki, Yoshinari Takasaki, Toshihiko Ishii, Koichi Suzuki, Meng Kian Tee and A. Hunter Shain and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Journal of Virology.

In The Last Decade

Takeshi Isoyama

29 papers receiving 605 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takeshi Isoyama Japan 11 334 166 135 114 76 30 620
Jiyeon Hyeon South Korea 18 217 0.6× 276 1.7× 56 0.4× 151 1.3× 168 2.2× 56 898
K Isono Japan 15 224 0.7× 145 0.9× 127 0.9× 20 0.2× 193 2.5× 60 611
Guido Bisping Germany 17 436 1.3× 302 1.8× 49 0.4× 23 0.2× 44 0.6× 28 845
Mihaela Ignat France 12 260 0.8× 99 0.6× 96 0.7× 15 0.1× 200 2.6× 22 621
Monica D. Traystman United States 12 191 0.6× 87 0.5× 66 0.5× 180 1.6× 60 0.8× 15 615
Kiyotaka Kurachi Japan 15 221 0.7× 372 2.2× 224 1.7× 22 0.2× 378 5.0× 65 897
Hiroaki Ohnishi Japan 16 291 0.9× 274 1.7× 256 1.9× 31 0.3× 49 0.6× 52 774
Takaaki Nakai Japan 12 132 0.4× 97 0.6× 104 0.8× 20 0.2× 117 1.5× 23 501
Pengfei Huang China 13 198 0.6× 168 1.0× 174 1.3× 10 0.1× 119 1.6× 23 565
Yuhsaku Kanoh Japan 13 203 0.6× 97 0.6× 66 0.5× 13 0.1× 46 0.6× 43 450

Countries citing papers authored by Takeshi Isoyama

Since Specialization
Citations

This map shows the geographic impact of Takeshi Isoyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeshi Isoyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeshi Isoyama more than expected).

Fields of papers citing papers by Takeshi Isoyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeshi Isoyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeshi Isoyama. The network helps show where Takeshi Isoyama may publish in the future.

Co-authorship network of co-authors of Takeshi Isoyama

This figure shows the co-authorship network connecting the top 25 collaborators of Takeshi Isoyama. A scholar is included among the top collaborators of Takeshi Isoyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeshi Isoyama. Takeshi Isoyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakazawa, Yusuke, Hiroyuki Okada, Yasuhito Nagamoto, et al.. (2024). Discovery of a potent, selective, and orally available EGFR C797S mutant inhibitor (DS06652923) with in vivo antitumor activity. Bioorganic & Medicinal Chemistry. 111. 117862–117862. 1 indexed citations
2.
Nagamoto, Yasuhito, et al.. (2023). Synthesis, activity, and their relationships of 2,4-diaminonicotinamide derivatives as EGFR inhibitors targeting C797S mutation. Bioorganic & Medicinal Chemistry Letters. 98. 129575–129575. 4 indexed citations
3.
Nagamoto, Yasuhito, Takahiro Jimbo, Takeshi Isoyama, et al.. (2020). 11P Preclinical evaluation of DS-2087b, a novel and selective inhibitor of EGFR/HER2 exon 20 insertions. Annals of Oncology. 31. S248–S248. 9 indexed citations
4.
Perl, Alexander E., Jörge E. Cortes, Siddhartha Ganguly, et al.. (2019). Effect of Co-Mutations and FLT3-ITD Variant Allele Frequency (VAF) on Response to Quizartinib or Salvage Chemotherapy (SC) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML). Blood. 134(Supplement_1). 737–737. 3 indexed citations
5.
Matsui, Yumi, Isao Yasumatsu, Ken Yoshida, et al.. (2018). A novel inhibitor stabilizes the inactive conformation of MAPK-interacting kinase 1. Acta Crystallographica Section F Structural Biology Communications. 74(3). 156–160. 13 indexed citations
6.
Jimbo, Takahiro, Naoyuki Maeda, Noriyasu Haginoya, et al.. (2017). P3.02-042 DS-1205b, a Novel, Selective, Inhibitor of AXL, Delays the Onset of Resistance and Overcomes Acquired Resistance to EGFR-TKIs. Journal of Thoracic Oncology. 12(11). S2252–S2252. 1 indexed citations
7.
8.
9.
10.
Isoyama, Takeshi, Shusuke Kuge, & Akio Nomoto. (2002). The Core Protein of Hepatitis C Virus Is Imported into the Nucleus by Transport Receptor Kap123p but Inhibits Kap121p-dependent Nuclear Import of Yeast AP1-like Transcription Factor in Yeast Cells. Journal of Biological Chemistry. 277(42). 39634–39641. 22 indexed citations
11.
Abe, Yusuke, et al.. (2002). Principle of the rotary undulation pump. Journal of Artificial Organs. 5(2). 84–90. 3 indexed citations
12.
Isoyama, Takeshi, Asako Murayama, Akio Nomoto, & Shusuke Kuge. (2001). Nuclear Import of the Yeast AP-1-like Transcription Factor Yap1p Is Mediated by Transport Receptor Pse1p, and This Import Step Is Not Affected by Oxidative Stress. Journal of Biological Chemistry. 276(24). 21863–21869. 60 indexed citations
13.
Shiroki, Kazuko, Takeshi Isoyama, Shusuke Kuge, et al.. (1999). Intracellular Redistribution of Truncated La Protein Produced by Poliovirus 3C pro -Mediated Cleavage. Journal of Virology. 73(3). 2193–2200. 93 indexed citations
14.
Isoyama, Takeshi, Nobuhiko Kamoshita, Kotaro Yasui, et al.. (1999). Lower concentration of La protein required for internal ribosome entry on hepatitis C virus RNA than on poliovirus RNA. Journal of General Virology. 80(9). 2319–2327. 45 indexed citations
15.
Abe, Yasuhiro, Tsuneo Chinzei, Takeshi Isoyama, et al.. (1996). LONG-TERM FEASIBILITY OF THE 1/R CONTROL LOGIC OF TOTAL ARTIFICIAL HEART - OVER 500 DAYS SURVIVAL WITH NO HEMODYNAMIC AND METABOLIC ABNORMALITY. ASAIO Journal. 42(2). 5–5. 1 indexed citations
16.
Isoyama, Takeshi, et al.. (1993). Submucosal tumors of the stomach: a study of 100 operative cases.. PubMed. 113(5). 498–506. 42 indexed citations
17.
Toyoshima, H., et al.. (1992). Clinicopathologic Study of Double Cancer:Colon and Sotmach.. Nihon Daicho Komonbyo Gakkai Zasshi. 45(7). 931–937. 1 indexed citations
18.
Isoyama, Takeshi, et al.. (1991). Total gastrectomy for gastric cancer in the elderly.. PubMed. 109(2). 136–42. 44 indexed citations
19.
Toyoshima, H., et al.. (1986). Surgical treatment of obstructing carcinoma of the left colon and its results.. Nihon Daicho Komonbyo Gakkai Zasshi. 39(6). 715–720. 1 indexed citations
20.
Sato, Takashi, Takeshi Isoyama, Jiro Tanaka, et al.. (1982). The pathophysiology of septic shock: changes in hemodynamics in rats following live E coli injection. An application of the thermodilution method for measurement of cardiac output.. PubMed. 7. 25–42. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiyeon Hyeon Breakdown of academic impact, for papers by K Isono Breakdown of academic impact, for papers by Guido Bisping Breakdown of academic impact, for papers by Mihaela Ignat Breakdown of academic impact, for papers by Monica D. Traystman Breakdown of academic impact, for papers by Kiyotaka Kurachi Breakdown of academic impact, for papers by Hiroaki Ohnishi Breakdown of academic impact, for papers by Takaaki Nakai Breakdown of academic impact, for papers by Pengfei Huang Breakdown of academic impact, for papers by Yuhsaku Kanoh
Rankless by CCL
2026